Why does C-reactive protein increase in non-ST elevation acute coronary syndromes? Role of myocardial damage

Vicent Bodí1, Julio Núñez, Juan Sanchis

  • 1Servei de Cardiología, Hospital Clínic i Universitari, Universitat de València, Avda Blasco Ibáñez 17, 46010 València, Spain. vicentbodi@hotmail.com

Insights

Elevated C-reactive protein in acute coronary syndromes is linked to myocardial damage. This finding helps explain its prognostic value, especially concerning regional heart dysfunction.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Medicine

Background:

  • C-reactive protein (CRP) is a key prognostic marker for acute coronary syndromes (ACS).
  • The precise mechanisms behind elevated CRP in ACS patients remain unclear.
  • Understanding these factors is crucial for accurate risk stratification.

Purpose of the Study:

  • To investigate factors associated with elevated C-reactive protein levels in patients with non-ST elevation acute coronary syndrome.
  • To explore the relationship between CRP and clinical, biochemical, and angiographic indicators of myocardial damage.

Main Methods:

  • A single-center registry study of 419 consecutive patients with non-ST elevation ACS.
  • High-sensitivity C-reactive protein (hs-CRP) measured median 3 days post-admission.
  • Multivariate analysis of clinical, ECG, biochemical, and angiographic data.

Main Results:

  • Elevated hs-CRP was associated with higher troponin I levels (OR 2.5) and Killip class >1 (OR 2.9).
  • No significant relationship was found between CRP and coronary angiographic characteristics.
  • Significant regional dysfunction (quantified by left ventriculography) was strongly related to elevated CRP (OR 5.1) in patients without prior heart disease.

Conclusions:

  • Late-elevated CRP in ACS is primarily linked to myocardial damage.
  • The prognostic significance of CRP may be partly explained by its association with major regional cardiac dysfunction.
  • These findings refine the understanding of CRP's role in ACS pathophysiology and prognosis.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...